Prevalence and molecular characterization of CTX-M extended-spectrum β-lactamase-producing Escherichia coli from 2000 to 2010 in Japan

Japanese Journal of Antibiotics

Volumn 68, Issue 2, 2015, Pages 75-84

  Hara, Takafumi ^a   Sato, Takafumi ^a   Horiyama, Tsukasa ^a   Kanazawa, Sachi ^a   Yamaguchi, Takahiro ^a   Maki, Hideki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CEFMETAZOLE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FLOMOXEF; LATAMOXEF; LEVOFLOXACIN; SULFAMETHOXAZOLE; BETA LACTAMASE; BETA-LACTAMASE CTX-M-14; BETA-LACTAMASE CTX-M-15; CTX-M-27, E COLI; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; DNA SEQUENCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITALIZATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; JAPAN; MICROBIAL SENSITIVITY TEST; TIME;

BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; JAPAN; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; TIME FACTORS;

EID: 84930061484     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. PITOUT, J. D. & K. B. LAUPLAND: Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. 8:159-166, 2008
2. SCHWABER, M. J. & Y. CARMELI: Mortality and delay in effective therapy associated with extendedspectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920, 2007
3. TUMBARELLO, M.; T. SPANU, R. D. BIDINO, ET AL: Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob. Agents Chemother. 54:4085-4091, 2010
4. STURENBURG, E. & D. MACK: Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J. Infect. 47:273-295, 2003
5. LIVEMORE, D. M.: Current epidemiology and growing resistance of Gram-negative pathogens. Korean J. Intern. Med. 27:128-142, 2012
6. PITOUT, J. D.: Infections with extended-spectrum β-Mactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333, 2010
7. PEIRANO, G.; D. RICHARDSON, J. NIGRIN, ET AL: High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectram-β-Mactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54:1327-1330, 2010
8. SUZUKI, S.; N. SHIBATA, K. YAMANE, ET AL: Change in the prevalence of extended-spectrum/Mactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63:72-79, 2009
9. YANO, H.; M. UEMURA, S. ENDO, ET AL: Molecular characteristics of extended-spectrum-β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital. J. PLoS ONE 8:e64359, 2013
10. KURODA, H.; H. YANO, Y. HIRAKATA, ET AL: Molecular characteristics of extended-spectrum/Mactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131. Diagn. Microbiol. Infect. 74:201-203, 2012
11. CLINICAL AND LABORATORY STANDARDS INSTITUTE. METHODS FOR DILUTION ANTIMICROBIAL SUSCEPTIBILITY TESTS FOR BACTERIA THAT GROW AEROBICALLY: Ninth edition. M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA. 2012
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty-third informational supplement. M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA. 2013
13. CHONG, Y.; S. SHIMODA, H. YAKUSHIJI, ET AL.: Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a longterm study in Japan. J. Med. Microbiol. 62:1038-1043, 2013
14. NAKAMURA, T.; M. KOMATSU, K. YAMASAKI, ET AL.: Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum-y-β-lactamases from clinical samples in the Kinki Region of Japan. Am. J. Clin. Pathol. 137:620-626, 2012
15. MATSUMURA, Y; M. YAMAMOTO, M. NAGAO, ET AL.: Emergence and spread of B2-ST131-025b, B2-ST131-016 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 67:2612-2620, 2012
16. BONNET, R.; C. RECULE, R. BARADUC, ET AL: Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52:29-35, 2003